Edgewise Therapeutics Inc. (NASDAQ:EWTX) on Wednesday shared updates from the ongoing CIRRUS-HCM Phase 2 trial of EDG-7500. EDG-7500 is an oral cardiac sarcomere modulator, specifically designed to slow early contraction velocity and address impaired cardiac relaxation associated with hypertrophic cardiomyopathy…
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) said on Wednesday that S&P Global Ratings upgraded its long-term issuer credit rating to BB+ from BB with a stable outlook, while Moody's affirmed its Ba1 rating and revised the outlook to positive. The actions…
The U.S. Food and Drug Administration (FDA) said it is aware that Medtronic Plc (NYSE:MDT) has notified customers to remove certain Left Heart Vent Catheters from use and sale, citing safety concerns. The catheter is used to vent the left…
Nvidia Corp. (NASDAQ:NVDA) recently stopped testing whether it would manufacture its advanced artificial intelligence chips using Intel Corp.’s (NASDAQ:INTC) 18A production process, according to people familiar with the matter. The pause represents a setback for Intel as it works to…
Gilead Sciences Inc. (NASDAQ:GILD) on Wednesday agreed to acquire Repare Therapeutics Inc.’s (NASDAQ:RPTX) polymerase theta (Polθ) ATPase inhibitor, RP-3467. RP-3467 is being evaluated in the POLAR Phase 1 trial to evaluate its safety, pharmacokinetics, pharmacodynamics, and preliminary activity alone or…
PowerBank Corporation (NASDAQ:SUUN) stock rose Wednesday after it received an initial $4 million payment for the previously announced Elmira, Jordan Road 1, and Jordan Road 2 projects. The company expects the remaining portion of the $41 million transaction as construction…
Daktronics, Inc. (NASDAQ:DAKT) on Tuesday announced the acquisition of intellectual property, equipment assets, and technical expertise from X Display Company Technology Limited (XDC), a specialist in mass-transfer processes and MicroLED technology. Financial terms were not disclosed. The Brookings, South Dakota–based…
The U.S. Food and Drug Administration (FDA) on Tuesday approved Agios Pharmaceuticals, Inc.’s (NASDAQ:AGIO) Aqvesme (mitapivat), an oral pyruvate kinase (PK) activator, for anemia in adults with alpha- or beta-thalassemia, a rare type of blood disorder that impacts hemoglobin production.…
Snowflake Inc. (NYSE:SNOW) is in talks to acquire application monitoring startup Observe Inc. for about $1 billion. The Information reported the potential deal on Wednesday, though the transaction has not yet been finalized. Observe offers a modern observability platform built…
Faraday Future Intelligent Electric Inc. (NASDAQ:FFAI) stock rose Wednesday after the company disclosed that its Middle East subsidiary inked a memorandum of understanding (MOU) with RAK Digital Assets Oasis (also known as RAK Innovation City). The MOU outlines plans for collaboration…